California Public Employees Retirement System Verastem, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.57 - $4.85 $891,533 - $1.68 Million	-346,900 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$1.15 - $2.4 $8,395 - $17,520	-7,300 Reduced 2.06%	346,900 $739,000
Q3 2020 Nov 05, 2020	BUY	$1.11 - $1.68 $25,752 - $38,976	23,200 Added 7.01%	354,200 $429,000
Q2 2020 Aug 12, 2020	BUY	$1.69 - $4.2 $424,190 - $1.05 Million	251,000 Added 313.75%	331,000 $569,000
Q2 2019 Aug 15, 2019	SELL	$1.25 - $3.14 $16,085 - $40,405	-12,868 Reduced 13.86%	80,000 $121,000
Q1 2019 May 03, 2019	BUY	$2.79 - $4.09 $35,901 - $52,630	12,868 Added 16.09%	92,868 $275,000
Q3 2018 Nov 13, 2018	SELL	$6.86 - $9.97 $48,020 - $69,790	-7,000 Reduced 8.05%	80,000 $580,000
Q2 2018 Aug 15, 2018	SELL	$2.88 - $8.67 $12,384 - $37,281	-4,300 Reduced 4.71%	87,000 $599,000
Q3 2017 Nov 15, 2017	BUY	$3.01 - $5.41 $274,813 - $493,933	91,300	91,300 $429,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$1.38 Million
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$293,760
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$122,400
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$18,268
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$6,572
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account